Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 92 pseudogene 2 (ZNF92P2) is a pseudogene in the human genome derived from zinc finger protein 92 (ZNF92), which encodes a zinc finger transcription factor[7][11]. Pseudogenes are segments of DNA that resemble functional genes but typically lack protein-coding ability due to mutations or truncations. ZNF92P2 does not encode a functional protein and has no known biological or disease function. The related protein-coding gene, ZNF92, has been linked with transcriptional regulation and is notably overexpressed in breast cancer, but ZNF92P2 itself is not a relevant biomarker, therapeutic target, or functional gene product[4][7][11]. Note: - The described gene, ZNF92P2, is a pseudogene, not a canonical receptor, enzyme, or other druggable target. - If your interest is in a functional transcription factor, you may be looking for zinc finger protein 92 (ZNF92), not ZNF92P2. - No evidence suggests ZNF92P2 is involved in disease, drug interactions, or has known safety or biomarker relevance[7][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 92 pseudogene 2 (ZNF92P2).